Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InspireMD Inc NSPR

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet... see more

Recent & Breaking News (NDAQ:NSPR)

InspireMD Hires Vice President of Corporate Development

PR Newswire April 19, 2013

InspireMD Closes $25 Million Underwritten Public Offering

PR Newswire April 16, 2013

InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT

PR Newswire April 10, 2013

InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent

PR Newswire March 15, 2013

InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock

PR Newswire March 7, 2013

InspireMD Announces 1 For 4 Reverse Split of Common Stock

PR Newswire December 20, 2012